Tải bản đầy đủ - 0 (trang)
Bảng 3.12: Tỷ lệ rối loạn lipid máu

Bảng 3.12: Tỷ lệ rối loạn lipid máu

Tải bản đầy đủ - 0trang

42



3.3.3. Mối tương quan giữa nồng độ 25(OH)D với vòng bụng

Bảng 3.12: Mối tương quan giữa nồng độ 25(OH)D với vòng bụng

Nồng độ 25(OH)D

Thiếu nặng

Thiếu vừa

Thiếu nhẹ

Bình thường



Trung bình vòng bụng(cm)



3.3.4. Mối tương quan giữa nồng độ 25(OH)D và rối loạn lipid máu

Bảng 3.13: Mối quan hệ giữa nồng độ 25(OH)D với rối loạn lipid máu

Nồng độ 25(OH)D

± SD

P



Có RL lipid

n



Không RL lipid

n



43



Chương 4

DỰ KIẾN BÀN LUẬN



DỰ KIẾN KẾT LUẬN



DỰ KIẾN KIẾN NGHỊ



TÀI LIỆU THAM KHẢO

1.



Wieder-Huszla S., Jurczak A., Szkup M., et al. (2019). Relationships

between Vitamin D3 and Metabolic Syndrome. Int J Environ Res Public

Health, 16(2).



2.



Berridge M.J. (2017). Vitamin D deficiency accelerates ageing and agerelated diseases: a novel hypothesis. J Physiol, 595(22), 6825–6836.



3.



Holick M.F. (2007). Vitamin D deficiency. N Engl J Med, 357(3), 266–281.



4.



Lee J.H., O’Keefe J.H., Bell D., et al. (2008). Vitamin D deficiency an

important, common, and easily treatable cardiovascular risk factor?. J

Am Coll Cardiol, 52(24), 1949–1956.



5.



Pittas A.G., Dawson-Hughes B., Li T., et al. (2006). Vitamin D and

calcium intake in relation to type 2 diabetes in women. Diabetes Care,

29(3), 650–656.



6.



Alberti K.G. and Zimmet P.Z. (1998). Definition, diagnosis and

classification of diabetes mellitus and its complications. Part 1: diagnosis

and classification of diabetes mellitus provisional report of a WHO

consultation. Diabet Med J Br Diabet Assoc, 15(7), 539–553.



7.



Balkau B. and Charles M.A. (1999). Comment on the provisional report

from the WHO consultation. European Group for the Study of Insulin

Resistance (EGIR). Diabet Med J Br Diabet Assoc, 16(5), 442–443.



8.



III) N.C.E.P. (NCEP) E.P. on D. Third Report of the National Cholesterol

Education Program (NCEP) Expert Panel on Detection, Evaluation, and

Treatment of High Blood Cholesterol in... - PubMed - NCBI.

,

accessed:

06/06/2019.



9.



Zimmet P., Magliano D., Matsuzawa Y., et al. (2005). The metabolic

syndrome: a global public health problem and a new definition. J

Atheroscler Thromb, 12(6), 295–300.



10. Alberti K.G.M.M., Eckel R.H., Grundy S.M., et al. (2009). Harmonizing

the metabolic syndrome: a joint interim statement of the International

Diabetes Federation Task Force on Epidemiology and Prevention;

National Heart, Lung, and Blood Institute; American Heart Association;

World Heart Federation; International Atherosclerosis Society; and

International Association for the Study of Obesity. Circulation, 120(16),

1640–1645.

11. Pokharel D.R., Khadka D., Sigdel M., et al. (2014). Prevalence of

metabolic syndrome in Nepalese type 2 diabetic patients according to

WHO, NCEP ATP III, IDF and Harmonized criteria. J Diabetes Metab

Disord, 13.

12. Pitsavos C., Panagiotakos D., Weinem M., et al. (2006). Diet, Exercise

and the Metabolic Syndrome. Rev Diabet Stud, 3(3), 118–126.

13. Ostrihoňová T., Rimárová K., Bérešová J., et al. (2017). Prevalence and

Trends of Metabolic Syndrome in Slovakia during the Period of 20032012. Cent Eur J Public Health, 25(4), 313–320.

14. Lee S.E., Han K., Kang Y.M., et al. (2018). Trends in the prevalence of

metabolic syndrome and its components in South Korea: Findings from

the Korean National Health Insurance Service Database (2009–2013).

PLoS ONE, 13(3).

15. Expert Panel on Detection, Evaluation, and Treatment of High Blood

Cholesterol in Adults (2001). Executive Summary of The Third Report

of The National Cholesterol Education Program (NCEP) Expert Panel on

Detection, Evaluation, And Treatment of High Blood Cholesterol In

Adults (Adult Treatment Panel III). JAMA, 285(19), 2486–2497.

16. Ferrannini E. and Natali A. (1991). Essential hypertension, metabolic

disorders, and insulin resistance. Am Heart J, 121(4 Pt 2), 1274–1282.

17. Athyros V.G., Ganotakis E.S., Elisaf M., et al. (2005). The prevalence of

the metabolic syndrome using the National Cholesterol Educational

Program and International Diabetes Federation definitions. Curr Med

Res Opin, 21(8), 1157–1159.



18. Santos A.-C., Lopes C., and Barros H. (2004). Prevalence of metabolic

syndrome in the city of Porto. Rev Port Cardiol Orgao Of Soc Port

Cardiol Port J Cardiol Off J Port Soc Cardiol, 23(1), 45–52.

19. Panagiotakos D.B., Pitsavos C., Chrysohoou C., et al. (2004). Impact of

lifestyle habits on the prevalence of the metabolic syndrome among

Greek adults from the ATTICA study. Am Heart J, 147(1), 106–112.

20. Reaven G.M. (1988). Role of Insulin Resistance in Human Disease.

Diabetes, 37(12), 1595–1607.

21. Reaven Gerald (2002). Metabolic Syndrome. Circulation, 106(3), 286–

288.

22. Pérez-Martínez P., Mikhailidis D.P., Athyros V.G., et al. (2017). Lifestyle

recommendations for the prevention and management of metabolic

syndrome: an international panel recommendation. Nutr Rev, 75(5), 307–

326.

23. Lips P. (2006). Vitamin D physiology. Prog Biophys Mol Biol, 92(1), 4–8.

24. Dusso A.S., Brown A.J., and Slatopolsky E. (2005). Vitamin D. Am J

Physiol-Ren Physiol, 289(1), F8–F28.

25. Cranney A., Horsley T., O’Donnell S., et al. (2007). Effectiveness and

safety of vitamin D in relation to bone health. Evid ReportTechnology

Assess, (158), 1–235.

26. Restrepo Valencia C.A. and Aguirre Arango J.V. Vitamin D (25(OH)D)

in patients with chronic kidney disease stages 2-5. Colomb Médica CM,

47(3), 160–166.

27. Gibney K.B., MacGregor L., Leder K., et al. (2008). Vitamin D

deficiency is associated with tuberculosis and latent tuberculosis

infection in immigrants from sub-Saharan Africa. Clin Infect Dis Off

Publ Infect Dis Soc Am, 46(3), 443–446.

28. Gombart A.F. (2009). The vitamin D–antimicrobial peptide pathway and

its role in protection against infection. Future Microbiol, 4, 1151.



29. Danik J.S. and Manson J.E. (2012). Vitamin D and Cardiovascular

Disease. Curr Treat Options Cardiovasc Med, 14(4), 414–424.

30. Wicherts I.S., van Schoor N.M., Boeke A.J.P., et al. (2007). Vitamin D

status predicts physical performance and its decline in older persons. J

Clin Endocrinol Metab, 92(6), 2058–2065.

31. Zerwekh J.E. (2008). Blood biomarkers of vitamin D status. Am J Clin

Nutr, 87(4), 1087S–91S.

32. Akter S., Eguchi M., Kurotani K., et al. (2017). Serum 25hydroxyvitamin D and metabolic syndrome in a Japanese working

population: The Furukawa Nutrition and Health Study. Nutr Burbank

Los Angel Cty Calif, 36, 26–32.

33. Pan G.-T., Guo J.-F., Mei S.-L., et al. (2016). Vitamin D Deficiency in

Relation to the Risk of Metabolic Syndrome in Middle-Aged and Elderly

Patients with Type 2 Diabetes Mellitus. J Nutr Sci Vitaminol (Tokyo),

62(4), 213–219.

34. Schmitt E.B., Nahas-Neto J., Bueloni-Dias F., et al. (2018). Vitamin D

deficiency is associated with metabolic syndrome in postmenopausal

women. Maturitas, 107, 97–102.

35. Lee S.H., Kim S.M., Park H.S., et al. (2013). Serum 25-hydroxyvitamin

D levels, obesity and the metabolic syndrome among Korean children.

Nutr Metab Cardiovasc Dis NMCD, 23(8), 785–791.



Mẫu bệnh án nghiên cứu

Số bệnh án:…….

MẪU PHIẾU BỆNH ÁN NGHIÊN CỨU



Mã số:……



I. HÀNH CHÍNH

- Họ và tên :

- Tuổi:

- Giới:

- Ngày vào viện:

- Chẩn đoán lúc vào:

- Chẩn đốn lúc ra:

II. LÂM SÀNG

- Lí do vào viện :

III. TIỀN SỬ

3.1 Khỏe mạnh

3.2 Tiền sử kinh nguyệt: tắt kinh bao nhiêu tháng

3.3 Các bệnh mạn tính khác

3.4 Các thuốc đang sử dụng

IV. MỘT SỐ CHỈ SỐ TOÀN THÂN

4.1. Huyết áp:…(mmHg)

4.2. Mạch:…(lần/ phút)

4.3. BMI:… (Kg/m2)

Cân nặng: …(kg)

chiều cao: …(cm)

4.4 Vòng bụng:…(cm)

V. MỘT SỐ XÉT NGHIỆM CẬN LÂM SÀNG

Glucose lúc đói:

Nồng độ vitamin D:

Mỡ máu: Cholesterol

Triglyceride

HDL-C

LDL-C



(mmol/l)

(ng/ml)

(mmol/l)

(mmol/l)

(mmol/l)

(mmol/l)



Tài liệu bạn tìm kiếm đã sẵn sàng tải về

Bảng 3.12: Tỷ lệ rối loạn lipid máu

Tải bản đầy đủ ngay(0 tr)

×